SCHEMBL7834640

SCHEMBL7834640

[CH2]c1ccc(NC(=O)CCCc2ccccc2)cc1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 1/20 0.75
HDAC1 Q13547 4/20 0.69
HDAC3 O15379 3/20 0.69
HDAC2 Q92769 3/20 0.69
HDAC8 Q9BY41 3/20 0.69
HDAC6 Q9UBN7 3/20 0.69
HDAC5 Q9UQL6 3/20 0.69
HDAC4 P56524 2/20 0.69
HDAC7 Q8WUI4 2/20 0.69
HDAC10 Q969S8 2/20 0.69
HDAC11 Q96DB2 2/20 0.69
HDAC9 Q9UKV0 2/20 0.69
NPC1 O15118 4/20 0.68
RAB9A P51151 4/20 0.68
MAPT P10636 2/20 0.68
KDM1A O60341 2/20 0.68
NFKB1 P19838 2/20 0.68
NFKB2 Q00653 2/20 0.68
RELA Q04206 2/20 0.68
SMN1; SMN2 Q16637 2/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7831891 0.94 HDAC1 (0.67) TRPV1HDAC1HDAC3HDAC2HDAC8
SCHEMBL8012743 0.89 TRPV1 (0.81) TRPV1HDAC1HDAC3HDAC2HDAC8
SCHEMBL7636110 0.86 TRPV1 (0.77) TRPV1HDAC1HDAC3HDAC2HDAC8
SCHEMBL19501635 0.86 TRPV1 (0.77) TRPV1HDAC1HDAC3HDAC2HDAC8
SCHEMBL8585476 0.85 HDAC4 (0.70) HDAC1HDAC3HDAC2HDAC8HDAC6
SCHEMBL1996813 0.84 TRPV1 (0.75) TRPV1HDAC1HDAC3HDAC2HDAC8
SCHEMBL4401159 0.84 TRPV1 (0.75) TRPV1HDAC1HDAC3HDAC2HDAC8
SCHEMBL18423189 0.84 TRPV1 (0.75) TRPV1HDAC1HDAC3HDAC2HDAC8
SCHEMBL18422082 0.83 TRPV1 (0.73) TRPV1HDAC1HDAC3HDAC2HDAC8
SCHEMBL8587620 0.82 MEN1 (0.69) TRPV1HDAC1HDAC3HDAC2HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0676398-B1 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO CO (JP) 2001-10-24 EP disclosed
US-6117893-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 2000-09-12 US disclosed
EP-1022274-A1 Oxazolidinedione and Thiazolidinedione derivatves, their preparation and their use Sankyo Company Limited (JP) 2000-07-26 EP disclosed
US-5977365-A HYPOGLYCEMIC AGENTS SANKYO COMPANY, LIMITED (JP) 1999-11-02 US disclosed
US-5962470-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 1999-10-05 US disclosed
US-5886014-A TREATMENT AND/OR PROPHYLAXIS OF A VARIETY OF DISORDERS, INCLUDING HYPERLIPEMIA, HYPERGLYCEMIA, OBESITY, IMPAIRED GLUCOSE TOLERANCE (IGT), INSULIN RESISTANCE AND DIABETIC COMPLICATIONS SANKYO COMPANY, LIMITED (JP) 1999-03-23 US disclosed
US-5834501-A TREATING DIABETES OR HYPERLIPEMIA SANKYO COMPANY, LIMITED (JP) 1998-11-10 US disclosed
US-5739345-A HYPOGLYCEMIC AND ANTIDIABETIC AGENTS SANKYO COMPANY, LIMITED (JP) 1998-04-14 US disclosed
US-5624935-A ANTIDIABETIC AGENTS, HYPOGLYCEMIC AGENTS OR ANTILIPEMIC AGENTS SANKYO COMPANY, LIMITED 1997-04-29 US disclosed
EP-0745600-A1 Benzimidazole derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-12-04 EP disclosed
EP-0676398-A2 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO COMPANY LIMITED (JP) 1995-10-11 EP disclosed